Table 1_Immune checkpoint inhibitor therapy in advanced cancer: clinical association of irAEs type, inflammatory markers and efficacy.docx

Table 1_Immune checkpoint inhibitor therapy in advanced cancer: clinical association of irAEs type, inflammatory markers and efficacy.docx

Background<p>Immune checkpoint inhibitors (ICIs) improve survival in advanced cancers but are associated with immune-related adverse events (irAEs), whose prognostic impact remains debated. The role of systemic inflammatory biomarkers is also not fully defined.</p>Methods<p>This re...

Fuld beskrivelse

Saved in:
Bibliografiske detaljer
Hovedforfatter: Mengying Qian (2541466) (author)
Andre forfattere: Ping Ma (15010) (author), Yu Zhao (104852) (author), Hao Jiang (95017) (author), LiYang Gao (22686257) (author), Gaoyang Lin (8495742) (author), Difan Duan (22686260) (author), Jinmin Guo (8665254) (author)
Udgivet: 2025
Fag:
Genetic Immunology
immune checkpoint inhibitors
inflammatory biomarkers
immune-related adverse events
overall survival
meta-analysis
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker